4basebio Operating Margin Growth & History (4BB)
4basebio's operating margin was −1,039.57% for fiscal 2025.
View full 4basebio company overview4basebio annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −1,039.57% | +251.10 pp |
| 2024 | 2024-12-31 | −1,290.68% | +323.16 pp |
| 2023 | 2023-12-31 | −1,613.83% | +501.46 pp |
| 2022 | 2022-12-31 | −2,115.30% | — |
4basebio operating margin trends
Between the periods ended 2022-12-31 and 2025-12-31, 4basebio's operating margin increased from −2,115.30% to −1,039.57%, a change of +1075.72 percentage points.
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
How operating margin is calculated
TickerStat calculates operating margin as reported operating income divided by reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review 4basebio source filings ↗Community posts
4basebio expands synthetic-DNA manufacturing for personalised mRNA medicines
4basebio announced an expansion of its DNA offering on 7 September 2026. Manufacturing changes The company has added suite capacity and enhanced process controls and quality systems across its Cambridge high-quality and current-GMP operatio ...